Sirolimus-eluting coronary stents

About Sirolimus-eluting coronary stents

Sirolimus-eluting coronary stents are designed to support long-term vessel patency by controlling excessive tissue growth within the artery. The controlled drug release helps improve healing while maintaining adequate blood flow to the heart muscle. Advin Health Care manufactures these stents with a strong focus on clinical reliability, safety, and consistent performance standards. These stents are widely used in interventional cardiology to support effective treatment of coronary artery disease and improve procedural outcomes.

• Sirolimus drug coating to help reduce restenosis

• Designed for controlled and uniform drug release

• Supports optimal vessel support after implantation

• Compatible with standard coronary stent delivery systems

Certifications

We are certified with CE, ISO 13485, and ISO 9001 standards.

Product Keywords

Sirolimus-Eluting Coronary Stents, Drug-Eluting Stent (DES), Coronary Artery Stent, Anti-Restenosis Stent, Interventional Cardiology

الدعامات التاجية المطلقة للسيروليموس، الدعامات الدوائية (DES)، دعامات الشريان التاجي، دعامات مضادة لتضيق الشريان التاجي، طب القلب التداخلي

Коронарные стенты с сиролимусом, стенты с лекарственным покрытием (DES), коронарные артериальные стенты, антирестенотические стенты, интервенционная кардиология

Stents coronarios liberadores de sirolimus, stent liberador de fármacos (SLF), stent de arteria coronaria, stent antirreestenosis, cardiología intervencionista

Stents coronaires à élution de sirolimus, stent à élution de médicament (DES), stent de l'artère coronaire, stent anti-resténose, cardiologie interventionnelle